Skip to main
MDT

Medtronic (MDT) Stock Forecast & Price Target

Medtronic (MDT) Analyst Ratings

Based on 18 analyst ratings
Buy
Strong Buy 17%
Buy 44%
Hold 39%
Sell 0%
Strong Sell 0%

Bulls say

Medtronic is a well-established and well-diversified company in the medical technology industry. With a strong product portfolio and a global presence, Medtronic is positioned for continued growth and success. Their recent divestment of the diabetes business may lead to short-term challenges, but their focus on new product launches and efficiency improvements should drive long-term growth. With potential upside drivers such as the acquisition of Scientia Vascular and better than expected sales and margins, Medtronic has the potential to outperform expectations and deliver strong returns for investors.

Bears say

Medtronic is expected to experience minimal dilution to its adjusted EPS in FY27 from the acquisition of Scientia Vascular and plans to continue pursuing tuck-in acquisitions to drive future organic growth, despite recent weakness in certain product categories leading to a lower 6.0% Y/Y organic growth in F3Q26, lower than our base case assumption.

Medtronic (MDT) has been analyzed by 18 analysts, with a consensus rating of Buy. 17% of analysts recommend a Strong Buy, 44% recommend Buy, 39% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Medtronic and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Medtronic (MDT) Forecast

Analysts have given Medtronic (MDT) a Buy based on their latest research and market trends.

According to 18 analysts, Medtronic (MDT) has a Buy consensus rating as of Jun 3, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $108.56, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $108.56, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Medtronic (MDT)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.